You Can Now Buy Lab-Grown Foie Gras
A lab-grown alternative to fattened duck liver offers a controversial future for the cultivated meat industry: as a luxury product for the few.
The Doctor Behind the ‘Suicide Pod’ Wants AI to Assist at the End of Life
The death of an American woman inside Philip Nitschke’s latest invention reveals the next frontier in the right-to-die debate.
Microsoft’s Three Mile Island Deal Signals a Broader Nuclear Comeback
Microsoft’s deal to bring back a Three Mile Island nuclear reactor is just one part of Big Tech’s quid pro quo with nuclear power.
The Push for Ad Agencies to Ditch Big Oil Clients
An activist coalition is pressuring firms to stop promoting fossil fuel companies—some of which have advertised oil and gas as “climate friendly.”
Those Most Likely to Get Covid Are Last in Line for Vaccines
Distribution plans that favor people with time and internet access hurt Black and Latinx people disproportionately.
Where Was the Battery at Tesla’s Battery Day?
Elon Musk made big promises at Tesla’s highly anticipated event. But a prototype never appeared, and it was unclear what the company had actually achieved.
Bitcoin Will Burn the Planet Down. The Question: How Fast?
A new paper concludes that it takes more than four times as much energy to mine $1 of bitcoin as mining $1 of copper.
Japanese Telecom Giant SoftBank Bets $1 Billion on the Clever Pharma Startup Roivant
SoftBank's aquisition-and-investment spree extends to a drug development business with a slick new strategy
What Biotech CEOs (and Their Funders) Learned From the Theranos Debacle
Biotech investors are still stunned by the rise and fall of the one-drop blood testing startup. But they're hellbent on making sure they don’t all get burned again.
Looks Like Google Bought Favorable Research to Lobby with
Two new reports contend that Google financed hundreds of papers that could help further its policy and regulatory goals.